177 related articles for article (PubMed ID: 33887476)
1. Universal Immunohistochemistry for Lynch Syndrome: A Systematic Review and Meta-analysis of 58,580 Colorectal Carcinomas.
Eikenboom EL; van der Werf-'t Lam AS; Rodríguez-Girondo M; Van Asperen CJ; Dinjens WNM; Hofstra RMW; Van Leerdam ME; Morreau H; Spaander MCW; Wagner A; Nielsen M
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e496-e507. PubMed ID: 33887476
[TBL] [Abstract][Full Text] [Related]
2. Unexplained mismatch repair deficiency: Case closed.
Eikenboom EL; Moen S; van Leeuwen L; Geurts-Giele WRR; Tops CMJ; van Ham TJ; Dinjens WNM; Dubbink HJ; Spaander MCW; Wagner A
HGG Adv; 2023 Jan; 4(1):100167. PubMed ID: 36624813
[TBL] [Abstract][Full Text] [Related]
3. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
Carethers JM; Stoffel EM
World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
[TBL] [Abstract][Full Text] [Related]
4. Universal Versus Targeted Screening for Lynch Syndrome: Comparing Ascertainment and Costs Based on Clinical Experience.
Erten MZ; Fernandez LP; Ng HK; McKinnon WC; Heald B; Koliba CJ; Greenblatt MS
Dig Dis Sci; 2016 Oct; 61(10):2887-2895. PubMed ID: 27384051
[TBL] [Abstract][Full Text] [Related]
5. Small Bowel Adenocarcinoma Frequently Exhibits Lynch Syndrome-associated Mismatch Repair Protein Deficiency But Does Not Harbor Sporadic MLH1 Deficiency.
Xia M; Singhi AD; Dudley B; Brand R; Nikiforova M; Pai RK
Appl Immunohistochem Mol Morphol; 2017 Jul; 25(6):399-406. PubMed ID: 27258561
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of yield and experiences of age-related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome.
Vos JR; Fakkert IE; Spruijt L; Willems RW; Langenveld S; Mensenkamp AR; Leter EM; Nagtegaal ID; Ligtenberg MJL; Hoogerbrugge N;
Int J Cancer; 2020 Oct; 147(8):2150-2158. PubMed ID: 32510614
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
[TBL] [Abstract][Full Text] [Related]
8. Identification of Lynch syndrome among patients with colorectal cancer.
Moreira L; Balaguer F; Lindor N; de la Chapelle A; Hampel H; Aaltonen LA; Hopper JL; Le Marchand L; Gallinger S; Newcomb PA; Haile R; Thibodeau SN; Gunawardena S; Jenkins MA; Buchanan DD; Potter JD; Baron JA; Ahnen DJ; Moreno V; Andreu M; Ponz de Leon M; Rustgi AK; Castells A;
JAMA; 2012 Oct; 308(15):1555-65. PubMed ID: 23073952
[TBL] [Abstract][Full Text] [Related]
9. Routine Molecular Analysis for Lynch Syndrome Among Adenomas or Colorectal Cancer Within a National Screening Program.
Goverde A; Wagner A; Bruno MJ; Hofstra RMW; Doukas M; van der Weiden MM; Dubbink HJ; Dinjens WNM; Spaander MCW
Gastroenterology; 2018 Nov; 155(5):1410-1415. PubMed ID: 30063919
[TBL] [Abstract][Full Text] [Related]
10. Universal screening to identify Lynch syndrome: two years of experience in a Northern Italian Center.
Chiaravalli AM; Carnevali I; Sahnane N; Leoni E; Furlan D; Berselli M; Sessa F; Tibiletti MG
Eur J Cancer Prev; 2020 Jul; 29(4):281-288. PubMed ID: 31609810
[TBL] [Abstract][Full Text] [Related]
11. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
Ryan NAJ; McMahon R; Tobi S; Snowsill T; Esquibel S; Wallace AJ; Bunstone S; Bowers N; Mosneag IE; Kitson SJ; O'Flynn H; Ramchander NC; Sivalingam VN; Frayling IM; Bolton J; McVey RJ; Evans DG; Crosbie EJ
PLoS Med; 2020 Sep; 17(9):e1003263. PubMed ID: 32941469
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of mismatch repair deficiency in ovarian cancer: A systematic review and meta-analysis.
Atwal A; Snowsill T; Dandy MC; Krum T; Newton C; Evans DG; Crosbie EJ; Ryan NAJ
Int J Cancer; 2022 Nov; 151(9):1626-1639. PubMed ID: 35792468
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of paired tumor and germline testing in evaluation of patients with Lynch-like syndrome in a large integrated healthcare setting.
Carwana H; Hoodfar E; Bergoffen J; Li D
Fam Cancer; 2021 Jul; 20(3):223-230. PubMed ID: 33215268
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic application of hMLH1 methylation in hereditary non-polyposis colorectal cancer.
Matsubara N
Dis Markers; 2004; 20(4-5):277-82. PubMed ID: 15528793
[TBL] [Abstract][Full Text] [Related]
15. Mismatch Repair Screening of Gastrointestinal Cancers: The Impact on Lynch Syndrome Detection and Immunotherapy.
R OM; J W; T F; C M; A W; N S; Z K
J Gastrointest Cancer; 2023 Sep; 54(3):768-775. PubMed ID: 36018445
[TBL] [Abstract][Full Text] [Related]
16. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer.
Pérez-Carbonell L; Ruiz-Ponte C; Guarinos C; Alenda C; Payá A; Brea A; Egoavil CM; Castillejo A; Barberá VM; Bessa X; Xicola RM; Rodríguez-Soler M; Sánchez-Fortún C; Acame N; Castellví-Bel S; Piñol V; Balaguer F; Bujanda L; De-Castro ML; Llor X; Andreu M; Carracedo A; Soto JL; Castells A; Jover R
Gut; 2012 Jun; 61(6):865-72. PubMed ID: 21868491
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers.
Georgeson P; Pope BJ; Rosty C; Clendenning M; Mahmood K; Joo JE; Walker R; Hutchinson RA; Preston S; Como J; Joseland S; Win AK; Macrae FA; Hopper JL; Mouradov D; Gibbs P; Sieber OM; O'Sullivan DE; Brenner DR; Gallinger S; Jenkins MA; Winship IM; Buchanan DD
Gut; 2021 Nov; 70(11):2138-2149. PubMed ID: 33414168
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H
Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011
[TBL] [Abstract][Full Text] [Related]
19. Histology of colorectal adenocarcinoma with double somatic mismatch-repair mutations is indistinguishable from those caused by Lynch syndrome.
Hemminger JA; Pearlman R; Haraldsdottir S; Knight D; Jonasson JG; Pritchard CC; Hampel H; Frankel WL
Hum Pathol; 2018 Aug; 78():125-130. PubMed ID: 29723603
[TBL] [Abstract][Full Text] [Related]
20. Worldwide prevalence of Lynch syndrome in patients with colorectal cancer: Systematic review and meta-analysis.
Abu-Ghazaleh N; Kaushik V; Gorelik A; Jenkins M; Macrae F
Genet Med; 2022 May; 24(5):971-985. PubMed ID: 35177335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]